Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | EIF2AK2 | P19525 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12816712 | 0.71 | APEX1 (0.44) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL7170676 | 0.69 | APEX1 (1.00) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL6660944 | 0.69 | APEX1 (0.60) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL12817864 | 0.67 | APEX1 (0.40) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL12817289 | 0.67 | TDP1 (0.43) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL5004546 | 0.67 | ALDH1A1 (0.36) | — | |
| SCHEMBL1047316 | 0.67 | — | — | |
| Water SCHEMBL28122788 | 0.67 | APEX1 (0.92) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL28013373 | 0.67 | APEX1 (0.56) | APEX1CA2CA4CA1CA6 | |
| SCHEMBL12816770 | 0.65 | TDP1 (0.41) | APEX1CA2CA4CA1CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10124326-B2 | Modified solid polyalkylaluminoxane and catalyst for olefin oligomerization reaction | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-11-13 | — | — | US | disclosed |
| US-20170225155-A1 | MODIFIED SOLID POLYALKYLALUMINOXANE AND CATALYST FOR OLEFIN OLIOGOMERIZATION REACTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-08-10 | — | — | US | disclosed |
| EP-3202822-A1 | MODIFIED SOLID POLYALKYLALUMINOXANE AND CATALYST FOR OLEFIN OLIGOMERIZATION REACTION | Sumitomo Chemical Company Limited (JP) | 2017-08-09 | — | — | EP | disclosed |
| WO-2012133921-A1 | CATALYST FOR OLEFIN OLIGOMERIZATION AND METHOD FOR PRODUCING α-OLEFIN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-04 | — | — | WO | disclosed |
| US-5639776-A | CROP PESTICIDE; NONPHYTOTOXIC, KIDNEY BEANS, ORANGES | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-06-17 | — | — | US | disclosed |
| US-5629406-A | AMINO ACID DERIVATIVES | SANKYO COMPANY, LIMITED (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0751130-A1 | 4,5-DIHYDROPYRAZOLE-5-THIONE DERIVATIVES AND ACARICIDE CONTAINING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-01-02 | — | — | EP | disclosed |
| EP-0587311-A1 | Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use | SANKYO COMPANY LIMITED (JP) | 1994-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170225155-A1 | MODIFIED SOLID POLYALKYLALUMINOXANE AND CATALYST FOR OLEFIN OLIOGOMERIZATION REACTION | OGFR, GFER, ITGB7 | APEX1 1598/4885CA2 4544/4885CA4 3955/4885 |
| US-10124326-B2 | Modified solid polyalkylaluminoxane and catalyst for olefin oligomerization reaction | GFER, OGFR, TECR | APEX1 1328/4885CA2 4602/4885CA4 4204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.